Apyx Medical (Apyx Medical) Float Percentage Of Total Shares Outstanding : 96.41% (As of May. 26, 2024)

View and export this data going back to 1994. Start your Free Trial

What is Apyx Medical Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Apyx Medical's float shares is 33.40 Mil. Apyx Medical's total shares outstanding is 34.64 Mil. Apyx Medical's float percentage of total shares outstanding is 96.41%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Apyx Medical's Insider Ownership is 6.33%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Apyx Medical's Institutional Ownership is 18.88%.

Apyx Medical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Apyx Medical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	33.40	/	34.64
	=	96.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apyx Medical (Apyx Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apyx Medical Corp (NAS:APYX) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

BOV:Germany

Address

5115 Ulmerton Road, Clearwater, FL, USA, 33760

Website

https://apyxmedical.com

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Executives

Todd Hornsby	officer: Executive Vice President	14321 HAWTHORNE DR., CARMEL IN 46033
Goodwin Charles D. Ii	director, officer: Chief Executive Officer	5115 ULMERTON ROAD, CLEARWATER FL 33760
Wendy Lauren Levine	director	75 KENMARE STREET, APT. 2D, NEW YORK NY 10012
Minnie Baylor-henry	director	C/O SCPHARMACUETICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01803
Tara Semb	officer: Chief Financial Officer	5516 RIVERSIDE HEIGHTS WAY, RICHMOND VA 23225
Craig A. Swandal	director	5115 ULMERTON ROAD, CLEARWATER FL 33760
Michael Geraghty	director	1342 CHERRY HILL ROAD, MENDOTA HEIGHTS MN 55118
Lawrence Waldman	director	5115 ULMERTON RD., CLEARWATER FL 33770
John C. Andres	director	86 CAPRI LANE, CHATHAM MA 02633
Jay D. Ewers	officer: Chief Financial Officer	4 MANHATTANVILLE ROAD, SUITE 106, PURCHASE NY 10577
J Robert Saron	director, officer: President
Robert Gershon	director, officer: Chief Executive Officer	5115 ULMERTON ROAD, CLEARWATER FL 33760
Mccarthy John J. Iii	officer: Chief CommercializationOfficer	23 RINALDO ROAD, NORTHPORT NY 11768
Scott Richard Davidson	director	C/O GREAT POINT PARTNERS, LLC, 165 MASON STREET, GREENWICH CT 06830
Moshe Citronowicz	officer: Vice President of Operations